This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by CHEN, H. J. Articles by MEITES, J. Search for Related Content PubMed PubMed Citation Articles by CHEN, H. J. Articles by MEITES, J.

Effects of Biogenic Amines and TRH on Release of Prolactin and TSH in the Rat¹

Department of Physiology, Michigan State University East Lansing, Michigan 48824

Abstract

The effects of a single injection of drugs on serum prolactin and TSH were determinedin male and in estrogen-primed ovariectomized rats. The precursor of serotonin, 5-hydroxytryptophan (5-HTP), produced a significant rise in serum prolactin and TSH, whereas para chloroamphetamine,a depletor of serotonin, elicited a fall in serum prolactin and TSH. -methylmetatyrosine (-MMT) and reserpine, both depressors of brain catecholamine (CA) and serotonin levels, evoked significant increases in serum prolactin and reductions in serum TSH. Injection of -MMT or reserpine together with 5-HTP further elevated serum prolactin but prevented any significant change in serum TSH. This suggests that the ability of -MMT and reserpine to inhibit TSH release is mediated through a reduction in brain serotonin and not via a decrease in CA. -methylparatyrosine, which inhibits CA synthesis without altering serotonin, evoked a marked increase in serum prolactin but had no effect on serum TSH. L-dopa administration significantly reduced serum prolactin values but had no significant effect on serum TSH.

Synthetic TRH increased both serum prolactin and TSH levels in male rats, but when it was injected after L-dopa administration, it did not elicit any rise in serum prolactin and evoked the same increase in serum TSH. This suggests that L-dopa acts directly or indirectly on the pituitary prolactin cells to inhibit TRH stimulation of prolactin release, but does not influence the action of TRH on pituitary TSH cells. Pilocarpine decreased serum prolactin, but had no significant effect on serum TSH values. The present study suggests that only serotonergic drugs produce similar effects on release of prolactin and TSH, whereas drugs that alter CA and pilocarpine depress prolactin release but have little or no effect on release of TSH. (Endocrinology 96: 10, 1975)

Footnotes

¹ This study was supported in part by NIH Research Grants AM-04784 from the Institute of Arthritis and Metabolic Diseases, and CA-10771 from the NationalCancer Institute.

Received December 20, 1973.

This article has been cited by other articles:

				M. E. Freeman, B. Kanyicska, A. Lerant, and G. Nagy Prolactin: Structure, Function, and Regulation of Secretion Physiol Rev, October 1, 2000; 80(4): 1523 - 1631. [Abstract] [Full Text] [PDF]

				C. Santana, L. Martin, F. Valladares, L. Diaz-Flores, C. Santana-Herrera, A. Milena, and M. R. Diaz Tryptophan ingestion by pregnant rats induces pituitary and mammary tumours in the adult female offspring Hum. Reprod., August 1, 1999; 14(8): 2155 - 2161. [Abstract] [Full Text] [PDF]

				I. Extein, A. L. C. Pottash, M. S. Gold, and R. W. Cowdry Using the Protirelin Test to Distinguish Mania From Schizophrenia Arch Gen Psychiatry, January 1, 1982; 39(1): 77 - 81. [Abstract] [PDF]